Abstract
Objective: To evaluate clinical and laboratory aspects of adolescents with Sickle Cell Disease treated with hydroxyurea. Methodology: a retrospective cohort study of patients with sickle cell anemia. The population will be adolescents who have been on hydroxyurea treatment for at least 2 years. Patients with other hemoglobinopathies, who abandoned treatment or died will be excluded. Data will be collected from medical records from September to October 2022. All ethical and legal principles will be respected and a significance level of 5% (p<0.05) will be considered.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
